Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer

Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer

Bibliographic Details
Main Authors: Janjigian, Yelena Y., Vakiani, Efsevia, Ku, Geoffrey Y., Herrera, Jessica M., Tang, Laura H., Bouvier, Nancy, Viale, Agnès, Socci, Nicholas D., Capanu, Marinela, Berger, Michael, Ilson, David H.
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537304/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537304/

Similar Items